Localized Injection of Lidocaine Via the Middle Meningeal Artery for Intractable Headache Treatment
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorDaniel A Tonetti, MD
About this trial
The goal of this clinical trial is to test whether injecting lidocaine into two blood vessels of the brain can help treat chronic headaches (migraines)
Eligibility criteria
Qualifiers
Age 18 years or above
Referred for diagnostic angiography
Diagnosis of intractable migraine
Written informed consent able to be obtained from subject
Disqualifiers
Baseline HIT-6 score less than 60 (severe)
Pregnant, breastfeeding, or unwilling to practice contraception during participation in the study
Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data
Concomitant intracranial pathology (eg, intracranial malignancy)
Trial design
Treatments tested in this trial
- Lidocaine (drug)
- Saline
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Daniel A Tonetti, MD
Lead sponsor
The Cooper Health System
Sponsor institution
Source ClinicalTrials.gov